Related Experiment Video
Updated: Oct 11, 2025

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
Published on: August 4, 2023
Role of Coagulation Profile in Predicting Disease Severity Among Patients of COVID-19
Animesh Saurabh1, Biswajit Dey1, Vandana Raphael1
1Pathology, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences (NEIGRIHMS), Shillong, IND.
Insights
Elevated D-dimer, fibrinogen, and prolonged prothrombin time (PT) indicate severe Coronavirus disease 19 (COVID-19). These coagulation markers are predictive of increased disease severity in SARS-CoV-2 patients.
Area of Science:
- Hematology and Coagulation
- Infectious Diseases
- Critical Care Medicine
Background:
- Coronavirus disease 19 (COVID-19), caused by SARS-CoV-2, impacts the coagulation system.
- Understanding coagulation abnormalities is crucial for assessing COVID-19 severity.
Purpose of the Study:
- To analyze the association between D-dimer, fibrinogen, prothrombin time (PT), and activated partial thromboplastin time (aPTT) with COVID-19 severity.
- To identify predictive cut-off values for these coagulation parameters in severe COVID-19 cases.
Main Methods:
- Retrospective study of 90 SARS-CoV-2 positive patients.
- Categorization of patients into severe and non-severe groups based on clinical outcomes.
- Analysis of admission D-dimer, fibrinogen, PT, and aPTT levels using independent t-test, Chi-square test, and ROC curve analysis.
Main Results:
- Severe COVID-19 patients (n=42) exhibited significantly higher D-dimer, fibrinogen, and PT levels compared to non-severe patients (n=48).
- Statistically significant p-values (<0.001 for D-dimer and PT, 0.005 for fibrinogen) confirmed these associations.
- Identified predictive cut-off values: D-dimer (0.99 mg/L), fibrinogen (349.5 mg/dL), and PT (13.05 seconds).
Conclusions:
- Elevated D-dimer and fibrinogen levels, along with prolonged PT, are significantly associated with severe COVID-19.
- These coagulation parameters serve as valuable predictors of disease severity in patients with SARS-CoV-2 infection.
Abstract:
Background Coronavirus disease 19 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), affects the coagulation cascade. In this retrospective study, we aimed to analyze the association of different coagulation parameters including that of D-dimer, fibrinogen, prothrombin time (PT), and activated partial thromboplastin time (aPTT) with severity in COVID-19 patients. Methodology A total of 90 patients positive for SARS-CoV-2 on real-time reverse transcription-polymerase chain reaction (rRT-PCR) were included in the study. The patients were categorized as severe and non-severe, and their D-dimer, fibrinogen, PT, and aPTT values on admission were evaluated. The association of the coagulation parameters with disease severity was analyzed by independent t-test and Chi-square test. The cut-off values of these parameters were calculated to predict the disease severity by receiver operator characteristic (ROC) curve. Results Out of 90 patients admitted, 42 patients were categorized as severe and the rest 48 patients were categorized as non-severe. D-dimer, fibrinogen, and PT in the severe group were significantly higher than the non-severe group with p-values of <0.001, 0.005, and <0.001, respectively. Cut-off values of 0.99 mg/L for D-dimer,349.5 mg/dL for fibrinogen, and 13.05 seconds for PT were predictive of disease severity among COVID-19 patients. Conclusion Severe COVID-19 patients showed significantly higher levels of D-dimer and fibrinogen and prolongation of PT as compared to non-severe COVID-19 patients. Higher levels of D-dimer and fibrinogen, and prolonged PT are predictive of increased disease severity among COVID-19 patients.
More Related Videos
Related Concept Videos
Coagulation
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

